TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31063082

Group type: EXPERIMENTAL
Intervention: Follow-up recommendations in radiology reports classified by a machine learning algorithm
Number of subjects: 318366

Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 318366

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 318366

Group type: EXPERIMENTAL
Intervention: CT studies
Number of subjects: 318366

Group type: COMPARATOR
Intervention: Radiologist sex, presence of a trainee, years in practice
Number of subjects: 318366

Group type: COMPARATOR
Intervention: Interradiologist variation
Number of subjects: 318366
Study: 28437215

Group type: EXPERIMENTAL
Intervention: New contraceptive users (initiated ≤60 days before enrollment)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Established contraceptive users (initiated >60 days before enrollment)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: New DMPA users
Number of subjects: 322

Group type: COMPARATOR
Intervention: Established DMPA users
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: New COC users
Number of subjects: 322

Group type: COMPARATOR
Intervention: Established COC users
Number of subjects: 322
Study: 25569624

Group type: EXPERIMENTAL
Intervention: Skimmed milk (600 mL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Orange drink (600 mL)
Number of subjects: 9
Study: 24660603

Group type: EXPERIMENTAL
Intervention: Chinese medication (established Chinese herbal formulas)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Western medication (leukotriene receptor antagonist and bronchial relaxant)
Number of subjects: 75
Study: 21494635

Group type: EXPERIMENTAL
Intervention: Ozone exposure (250 ppb)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Clean air exposure
Number of subjects: 14
Study: 18483475

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment with enhanced food monitoring accuracy (EFMA) plus reduced energy density eating (REDE)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Reduced energy density eating (REDE)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 103
Study: 16410033

Group type: EXPERIMENTAL
Intervention: Exercise ball
Number of subjects: 15

Group type: COMPARATOR
Intervention: Wooden stool
Number of subjects: 15

Group type: COMPARATOR
Intervention: Chair
Number of subjects: 15
Study: 15213472

Group type: EXPERIMENTAL
Intervention: Treadmill exercise group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual exercise group
Number of subjects: 32
Study: 10858364

Group type: EXPERIMENTAL
Intervention: Zanamivir (Relenza)
Number of subjects: 0
Study: 9374583

Group type: EXPERIMENTAL
Intervention: vapocoolant spray + distraction
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: EMLA cream + distraction
Number of subjects: 62

Group type: COMPARATOR
Intervention: distraction alone (control)
Number of subjects: 62
Study: 8247189

Group type: EXPERIMENTAL
Intervention: Prednisone 60 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Retrobulbar radiotherapy (control)
Number of subjects: 0
Study: 3033180

Group type: EXPERIMENTAL
Intervention: enalapril 20 mg daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: atenolol 50 mg daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: enalapril (higher dose if diastolic BP > 90 mmHg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: atenolol (higher dose if diastolic BP > 90 mmHg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 48
Study: 30551048

Group type: EXPERIMENTAL
Intervention: tDCS-Before
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: tDCS-During
Number of subjects: 80
Study: 29923305

Group type: EXPERIMENTAL
Intervention: LI85008F (900 mg/d in two divided doses)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LI85008F
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 26280946

Group type: EXPERIMENTAL
Intervention: L-arginine (ARG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20
Study: 25380894

Group type: EXPERIMENTAL
Intervention: Myfenax
Number of subjects: 60

Group type: COMPARATOR
Intervention: Other formulations of mycophenolate
Number of subjects: 60
Study: 22200567

Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (hygiene domain)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (dressing domain)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (pain domain)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Stroke-Adapted Sickness Impact Profile
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Stroke-Adapted Sickness Impact Profile (physical dimension)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Caregiver burden related to hygiene and dressing domain severity
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Caregiver assistance requirement (hygiene domain)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Caregiver assistance requirement (dressing domain)
Number of subjects: 279
Study: 19864311

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 173
Study: 17852173

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy for complicated grief
Number of subjects: 51

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 51
Study: 16046981

Group type: EXPERIMENTAL
Intervention: 2 L PEG‐E with a regular diet the day before colonoscopy followed by another 2 L PEG‐E on the day of the procedure (Group B)
Number of subjects: 141

Group type: COMPARATOR
Intervention: 4 L PEG‐E with a liquid diet the day before colonoscopy (Group A)
Number of subjects: 141
Study: 12104065

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Both statins
Number of subjects: 5
Study: 10588465

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (daily intake: 216 mg eicosapentaenoic acid, 140 mg docosahexaenoic acid, 390 mg gamma‐linolenic acid, and 3480 mg linoleic acid)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 8817707

Group type: EXPERIMENTAL
Intervention: Community-based psychiatric services
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hospital-based psychiatric services
Number of subjects: 100
Study: 1673616

Group type: EXPERIMENTAL
Intervention: Isradipine 1.25 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isradipine combined with 1 mg/day bopindolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 20
Study: 7282610

Group type: EXPERIMENTAL
Intervention: Complex carbohydrate diet (approximately 3000 kcal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex carbohydrate diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing amounts of carbohydrate (88 to 648 g carbohydrate/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Frequent feedings of a high carbohydrate diet
Number of subjects: 0
Study: 31971089

Group type: EXPERIMENTAL
Intervention: Vitamin D (4000 IU of Vit D3 daily for 4 weeks)
Number of subjects: 32
Study: 29260292

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU daily for 3 years)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 27796132

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Er:YAG laser
Number of subjects: 20
Study: 26208981

Group type: EXPERIMENTAL
Intervention: Patients with bipolar disorder
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 23018287

Group type: EXPERIMENTAL
Intervention: Metronome sound-guided group (MG)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 67
Study: 22090672

Group type: EXPERIMENTAL
Intervention: Physical Exercise (NG II) - brisk walking for 50 to 60 minutes, three to four days/week
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Salt Intake Reduction (NG III) - to at least half of their previous intake
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Yoga (NG IV) - for 30 to 45 minutes/day, five days/week
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control Group (New Group I)
Number of subjects: 98
Study: 18477130

Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Re-PUVA
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: NB-UVB
Number of subjects: 46
Study: 16673797

Group type: EXPERIMENTAL
Intervention: Metronidazole cream (0.75% and 1%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole gel (0.75% and 1%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole lotion (0.75% and 1%)
Number of subjects: 0
Study: 14700089

Group type: EXPERIMENTAL
Intervention: ABCD program
Number of subjects: 437

Group type: COMPARATOR
Intervention: Regular benefits
Number of subjects: 437
Study: 9785682

Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (35 degrees C‐37 degrees C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (28 degrees C)
Number of subjects: 90
Study: 7631329

Group type: EXPERIMENTAL
Intervention: Active blood pressure treatment
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 2115856

Group type: EXPERIMENTAL
Intervention: 1,000 micrograms GHRH with water
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1,000 micrograms GHRH with water plus Tween 80
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 micrograms intravenous GHRH
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1276770

Group type: EXPERIMENTAL
Intervention: General anaesthetic technique A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General anaesthetic technique B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 7308953

Group type: EXPERIMENTAL
Intervention: Piroxicam (Felden), applied once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin retard, applied twice daily (43% of cases) or sometimes (14%)
Number of subjects: 0
Study: 29596010

Group type: EXPERIMENTAL
Intervention: Higher intensity whole body vibration (amplitude 8.82 mm, g force 2.76)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low intensity whole body vibration (amplitude 4.53 mm, g force 2.21)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Other outcome measures
Number of subjects: 15
Study: 30591069

Group type: EXPERIMENTAL
Intervention: Brief medication review combined with a standardised communication strategy at hospital discharge
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2100
Study: 26880173

Group type: EXPERIMENTAL
Intervention: IV access present (Group 1: n = 27)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No IV access present (Group 2: n = 19)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intramuscular administration
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intravenous administration
Number of subjects: 46
Study: 24839251

Group type: EXPERIMENTAL
Intervention: Acute total sleep deprivation (TSD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal sleep (8.5 hours)
Number of subjects: 14
Study: 22549117

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (2400 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No compound (control)
Number of subjects: 22
Study: 19027366

Group type: EXPERIMENTAL
Intervention: Oestrogen/progestin hormone therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective oestrogen receptor modulators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 0
Study: 17709852

Group type: EXPERIMENTAL
Intervention: 2-week staged bilateral arthroplasties
Number of subjects: 90

Group type: COMPARATOR
Intervention: Matched randomised controls (unilateral arthroplasties)
Number of subjects: 90
Study: 16302862

Group type: EXPERIMENTAL
Intervention: FAST-KD
Number of subjects: 48

Group type: COMPARATOR
Intervention: GRAD-KD
Number of subjects: 48
Study: 11863154

Group type: EXPERIMENTAL
Intervention: 4.4 ml lidocaine with 1:80,000 epinephrine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4.4 ml 3% prilocaine with 0.031 U/ml felypressin
Number of subjects: 30
Study: 10445367

Group type: EXPERIMENTAL
Intervention: NaF gel (1%)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: SnF2 gel (1%)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 280
Study: 8539345

Group type: EXPERIMENTAL
Intervention: Ethanol (0.8 g/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Diazepam (20 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (for both experiments)
Number of subjects: 45
Study: 2189696

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group with Continuous Positive Pressure Ventilation (CPPV)
Number of subjects: 55
Study: 229983

Group type: EXPERIMENTAL
Intervention: Irradiation plus CCNU (36 cases)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Irradiation plus BCNU (34 cases)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Irradiation alone (32 cases)
Number of subjects: 102
Study: 31652344

Group type: EXPERIMENTAL
Intervention: Zolpidem hemitartrate formulation (5 mg orodispersible tablet)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Zolpidem hemitartrate formulation (5 mg sublingual tablet)
Number of subjects: 30
Study: 31080095

Group type: EXPERIMENTAL
Intervention: Whole-body MRI (WB-MRI)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard pathways
Number of subjects: 370
Study: 28049139

Group type: EXPERIMENTAL
Intervention: MK-2206
Number of subjects: 43

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 43
Study: 26304466

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/d
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg/d
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study: 23915042

Group type: EXPERIMENTAL
Intervention: Placebo analgesic treatments (choice between treatments)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Placebo treatment (choice of treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory discomfort paradigm (choice between treatments)
Number of subjects: 0
Study: 20689466

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestogen therapy
Number of subjects: 1941

Group type: EXPERIMENTAL
Intervention: Estrogen therapy alone
Number of subjects: 1941

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1941
Study: 19298337

Group type: EXPERIMENTAL
Intervention: 14-day regimen with 500 mg clarithromycin b.i.d., 500 mg metronidazole t.i.d., and 500 mg amoxicillin t.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-day regimen containing 500 mg clarithromycin b.i.d., 1 g amoxicillin b.i.d., and 20 mg omeprazole b.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 14-day clarithromycin, metronidazole, and amoxicillin regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-day clarithromycin, amoxicillin, and omeprazole regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with atrophic gastritis receiving clarithromycin, metronidazole, and amoxicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with atrophic gastritis receiving clarithromycin, amoxicillin, and omeprazole
Number of subjects: 0
Study: 18021144

Group type: EXPERIMENTAL
Intervention: Skin-to-skin group (n = 44)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Mother's arms group (n = 44)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Nursery group (n = 88)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Infant foot temperature in skin-to-skin group
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Maternal axillar temperature
Number of subjects: 176
Study: 15469650

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (40 min at 40% VO2max) performed 3.5 hours after the test meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (40 min at 40% VO2max) performed the afternoon before the test meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 12
Study: 12613400

Group type: EXPERIMENTAL
Intervention: Yogic breathing exercises (pranayama)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9519749

Group type: EXPERIMENTAL
Intervention: Picotamide, 300 mg, 3 tablets/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo, 3 tablets/day
Number of subjects: 30
Study: 7857349

Group type: EXPERIMENTAL
Intervention: pidotimod
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 2699544

Group type: EXPERIMENTAL
Intervention: Kanamicine sulphate daily for 6 days followed by polidesossiribonucleotide for 24 days
Number of subjects: 303

Group type: COMPARATOR
Intervention: Untreated (control group)
Number of subjects: 303
Study: 1000518

Group type: EXPERIMENTAL
Intervention: Regimen A: DTIC, vincristine, BCNU
Number of subjects: 274

Group type: COMPARATOR
Intervention: Regimen B: DTIC, vincristine, hydroxyurea
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Regimen C: DTIC, actinomycin D, BCNU
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Regimens A and C
Number of subjects: 274
Study: 29072092

Group type: EXPERIMENTAL
Intervention: Six-week outpatient rehabilitation programme followed by a six-week home exercise programme
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (delayed-start rehabilitation programme)
Number of subjects: 19
Study: 28224927

Group type: EXPERIMENTAL
Intervention: Age- and sex-specific gene expression score (ASGES) >15
Number of subjects: 2370

Group type: COMPARATOR
Intervention: Noninvasive testing
Number of subjects: 2370
Study: 26635079

Group type: EXPERIMENTAL
Intervention: 16 g/d prebiotic supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 30
Study: 23605175

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (eight weekly individual phone sessions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (scripted follow-up phone call)
Number of subjects: 45
Study: 21382514

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum (test group)
Number of subjects: 2720

Group type: COMPARATOR
Intervention: Control group (unspecified)
Number of subjects: 2720
Study: 19145092

Group type: EXPERIMENTAL
Intervention: Permanent prostate brachytherapy (PB)
Number of subjects: 231
Study: 16642608

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Yongquan (KI 1) plus antiemetic
Number of subjects: 88

Group type: COMPARATOR
Intervention: Antiemetic only (Control)
Number of subjects: 88
Study: 14669032

Group type: EXPERIMENTAL
Intervention: Therapy (not specified)
Number of subjects: 106
Study: 10992837

Group type: EXPERIMENTAL
Intervention: Korean hand acupressure performed 30 min before induction of anaesthesia, applied to the K-K9 acupuncture point, disc remained for at least 24 h.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group, no specific intervention details provided.
Number of subjects: 0
Study: 8559421

Group type: EXPERIMENTAL
Intervention: Vigabatrin 3 g/day
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 1893304

Group type: EXPERIMENTAL
Intervention: Prazosin (10 mg bid, titrated to 18.6 +/- 0.7 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6407410

Group type: EXPERIMENTAL
Intervention: Weekly exchange of CVC via a guidewire
Number of subjects: 62

Group type: COMPARATOR
Intervention: Historical controls (not specified in detail)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: CVC exchange
Number of subjects: 62
Study: 30412234

Group type: EXPERIMENTAL
Intervention: Pictorial + text health-warning message
Number of subjects: 1859

Group type: COMPARATOR
Intervention: No health-warning message
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Fruit-flavored varieties
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Lower nicotine content (0.0% vs. 0.05% vs. 0.5%)
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Lower prices
Number of subjects: 1859
Study: 30474735

Group type: EXPERIMENTAL
Intervention: Interrupted Sutures (IS)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Continuous Sutures (CS)
Number of subjects: 161
Study: 28929068

Group type: EXPERIMENTAL
Intervention: Endoscopic myringoplasty
Number of subjects: 120

Group type: COMPARATOR
Intervention: Microscopic myringoplasty
Number of subjects: 120
Study: 25645091

Group type: EXPERIMENTAL
Intervention: Oxalobacter formigenes (700 million, twice a day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Potassium magnesium citrate (30 mEq, twice a day)
Number of subjects: 80
Study: 23539907

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg/16 mg as add-on therapy to ACE-inhibitors
Number of subjects: 35
Study: 20931329

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19011428

Group type: EXPERIMENTAL
Intervention: Ziprasidone (40 mg single dose)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Haloperidol (7.5 mg single dose)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ziprasidone (steady-state treatment)
Number of subjects: 23